RE:RE:RE:RE:It takes $200 Million plus for a Phase III approval I am really having a hard time believing this guy is ceo of public company. I don't think someone in that postion would be dumb enough to open themselves up to serous legal issues by repeatedly postinh that a roll back is definitely happening when they have zero proof of that. I see that is backpedaling a little bit now and saying he only thinks this will happen, but he presented it as absolute fact since November. Only with several board members attacking his post did he soften it.
Doinitmyway wrote:
Jeff.....the 70 million you keep tossing around (if that amount is even accurate) would be the final amount needed as you say under orphan drug status. You are talking about several years before phase 3 is complete. Which gives plenty of time to secure funding via many means, ample time for share price to increase as well (helping to secure funding more so), company gets bought out (negating need for funding) and don't forget the companies plans for roll out of cannabis dispensary across the EU under pharmadrug and the shroom business expansion expanding under Slim Winkel in the Netherlands and I believe the EU as well....which will all contribute to bottom line and increasing share value. With all that said I struggle to see your point with the urgency to come up with this quoted 70 million at your fever pitch. Read up before you bash eh....